Prevalence and phenotypes of congenital myopathy due to α-actin 1 gene mutations

19 Citations (Scopus)

Abstract

INTRODUCTION: Congenital myopathy due to mutations in the α-actin 1 gene (ACTA1) was identified in 1999, but knowledge of prevalence and phenotype in patients who survive 5 years is lacking.

METHODS: A national cohort of 91 patients aged ≥5 years and diagnosed with congenital myopathy was assessed for ACTA1 mutations and investigated clinically.

RESULTS: Four patients with ACTA1 mutations were identified, yielding a prevalence of 4.4%. Patients were 10-23 years of age, and all but 1 were ambulatory. Vital capacity ranged from 47% to 70% predicted, and 1 patient needed nocturnal bi-level positive airway pressure. Limb flexor/extensor muscles and upper and lower extremities were affected equally. Pronounced neck flexor weakness was noted.

CONCLUSIONS: Congenital myopathy caused by ACTA1 mutations is fatal in infancy in most cases. This study shows that the prevalence of α-actin myopathy in older patients with congenital myopathy is not negligible and that phenotypes can be quite mild. Muscle Nerve, 2015.

Original languageEnglish
JournalMuscle & Nerve
Volume53
Issue number3
Pages (from-to)388–393
ISSN0148-639X
DOIs
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Prevalence and phenotypes of congenital myopathy due to α-actin 1 gene mutations'. Together they form a unique fingerprint.

Cite this